Russell S Berman

Years Active: 2020-2022
Publications (10 Years): 5

NYU Langone Medical Center

New York University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NYU Langone Medical Center Aug 15 2000

United States

Chief of Surgical Oncology, Director Residency Program :: Surgery

NYU School of Medicine Jul 01 1990

United States

Associate Professor of Surgery (Academic) :: Surgery. Breast Surgery

University of Texas MD Anderson Cancer Center Jul 01 1997 - Jun 30 2000

United States

Fellow/ Junior Faculty Associate :: Surgical Oncology

Education History

New York University School of Medicine Sep 01 1988 - May 15 1990

United States

PHD

Sophie Davis School of Biomedical Education Sep 01 1983 - Jun 15 1988

United States

BSC

Publications

Sarah R Kaslow, Greg D Sacks, Russell S Berman, Ann Y Lee, Camilo Correa-Gallego
Natural History of Stage IV Pancreatic Cancer. Identifying Survival Benchmarks for Curative-intent Resection in Patients With Synchronous Liver-only Metastases. Annals of surgery (2022)
Sarah R Kaslow, Zhongyang Ma, Leena Hani, Katherine Prendergast, Gerardo A Vitiello, Ann Y Lee, Russell S Berman, Judith D Goldberg, Camilo Correa-Gallego
Adherence to guidelines at the patient- and hospital-levels is associated with improved overall survival in patients with gastric cancer. Journal of surgical oncology 126 (3) (2022)
Gerardo A Vitiello, Annie Wang, Rachel M Lee, Maria C Russell, Adam Yopp, Emily L Ryon, Neha Goel, Sommer Luu, Cary Hsu, Eric Silberfein, Camilo Correa-Gallego, Russell S Berman, Ann Y Lee
Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitals. Journal of surgical oncology 123 (4) (2021)
Ann Y Lee, Keith A Delman, Russell S Berman
Development of a surgical oncology training curriculum for accreditation. Journal of surgical oncology 122 (1) (2020)
Benjamin D Medina, Beatrix Hyemin Choi, Kathy G Rodogiannis, Una Moran, Richard L Shapiro, Anna Pavlick, Iman Osman, Russell S Berman, Ann Y Lee
Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy. Journal of surgical oncology 122 (3) (2020)

Russell S Berman.css-eqlu8i{font-size:small;padding-left:4px;}